An anti-nausea drug may reduce recurrence and death in aggressive breast cancer. Scientists are exploring its broader use in oncology. A recent study has identified a link between a widely used anti-nausea drug and improved outcomes for women with early-stage breast cancer, with especially notable effects in those with triple negative breast cancer. Researchers from […]



Summary

A common anti-nausea drug shows promise in combating aggressive early-stage breast cancer, particularly triple negative. A recent study suggests it significantly reduces recurrence and death rates in women with this type of cancer. While the study details are not fully available, the findings are prompting scientists to investigate the drug’s wider potential in oncology. This unexpected benefit could offer a new, readily available treatment option for a challenging form of breast cancer.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer